The multidrug resistance phenotype: P-glycoprotein, regulation of the mdr genes and other related mechanisms

This publication has 153 references indexed in Scilit:

• The Region 3′ to the Major Transcriptional Start Site of the MDR1 Downstream Promoter Mediates Activation by a Subset of Mutant P53 Proteins
  Biochemical and Biophysical Research Communications, 1995
• Reconstitution of purified P-glycoprotein into liposomes
  Zeitschrift für Krebsforschung und Klinische Onkologie, 1995
• Reversal of P-glycoprotein-associated multidrug resistance: The challenge continues
  European Journal Of Cancer, 1993
• Circumvention of chemotherapy-induced myelosuppression by transfer of themdr1 gene
  Biotherapy, 1993
• Role of cell cholesterol in modulating vincristine uptake and resistance
  International Journal of Cancer, 1993
• Involvement of protein kinase in environmental stress‐induced activation of human multidrug resistance 1 (MDR1) gene promoter
  FEBS Letters, 1993
• The p53 tumour suppressor gene
  Nature, 1991
• Regulation of the mevalonate pathway
  Nature, 1990
• Doxorubicin resistance in P388 leukemia—evidence for reduced drug influx
  International Journal of Cancer, 1989
• The mdrl gene, responsible for multidrug-resistance, codes for P-glycoprotein
  Biochemical and Biophysical Research Communications, 1986